Vasculopathy and insulin resistance in the JCR:LA-cp rat

Atherosclerosis

Volumn 138, Issue 1, 1998, Pages 135-146

  Richardson, Mary ^a   Schmidt, Ann Marie ^b   Graham, Sandra E ^c   Achen, Blaine ^c   DeReske, Marnie ^a   Russell, James C ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b The New York Presbyterian Hospital   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Insulin resistance; JCR:LA cp rat; Miglitol; Vascular lesions; Vascular relaxation

Indexed keywords

INSULIN;

ANIMAL EXPERIMENT; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; BLOOD VESSEL TONE; DISEASE ASSOCIATION; HORMONAL REGULATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ANIMALS; ARTERIES; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPERINSULINISM; INSULIN RESISTANCE; MALE; MICROSCOPY, ELECTRON; OBESITY; RATS; RATS, INBRED STRAINS; VASCULAR CELL ADHESION MOLECULE-1; VASCULAR DISEASES; VASODILATION;

EID: 0032076232     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00012-4     Document Type: Article

References (53)

1. Reaven G.M. Syndrome X: 6 years later. J Intern Med. 736(Suppl):1994;13-22.
2. Stout R.W. Insulin and atheroma 20-year perspective. Diabetes Care. 13:1990;631-654.
3. Steiner G. Hyperinsulinemia and hypertriglyceridemia. J Intern Med 1994;736(Suppl):23-26.
4. Zavaroni I., Bonora E., Pagliaro M.et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 320:1989;702-706.
5. Sowers J.R., Sowers P.S., Peuler J.D. Role of insulin resistance and hyperinsulinemia in development of hypertension and atherosclerosis. J Lab Clin Med. 123:1994;647-652.
6. Godsland I.F., Crook D., Walton C., Wynn V., Oliver M.F. Influence of insulin resistance, secretion, and clearance on serum cholesterol, triglycerides, lipoprotein cholesterol, and blood pressure in healthy men. Arterioscler Thromb. 12:1992;1030-1035.
7. Fuh M.M.-T., Jeng C.-Y., Young M.M.-S., Sheu W.H.-H., Chen Y.-D.I., Reaven G.M. Insulin resistance, glucose intolerance, and hyperinsulinemia in patients with microvascular angina. Metab Clin Exp. 42:1993;1090-1092.
8. Langes K., Nienaber C.A., Volk C., Schneider M.A.E., Koschyk D.H., Rinninger F., Meinertz T. Insulin resistance and hyperlipoproteinemia in microvascular angina: Risk factors or pathogenetic link? Coronary Artery Dis. 6:1995;797-804.
9. Laakso M., Sarlund H., Salonen R., Suhonen M., Pyorala K., Salonen J.T., Karhapaa P. Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb. 11:1991;1068-1076.
10. Uusitupa M.I.J., Niskanen L.K., Siitonen O., Voutilainen E., Pyorala K. Five year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. Circulation. 82:1990;27-36.
11. Savage P.J., Saad M.F. Insulin and atherosclerosis: Villain, accomplice, or innocent bystander? Br Heart J. 69:1993;473-475.
12. Lakka T.A. Lakka H-M, Salonen J.T. Hyperinsulinemia and the risk of coronary heart disease. N Engl J Med. 335:1966;976-977.
13. Saffran M. Is insulin a factor in the genesis of the vascular complications of diabetes? Trends Endocrin Metab. 1:1989;56-59.
14. Stern M.P. Diabetes and cardiovascular disease: The "common soil" hypothesis. Diabetes. 44:1995;369-374.
15. Welborn T.A., Knuiman M.W., Ward N., Whittall D.E. Serum insulin is a risk marker for coronary heart disease mortality in men but not in women. Diabetes Res Clin Pract. 26:1994;51-59.
16. Fontbonne A. Insulin: A sex hormone for cardiovascular risk? Circulation. 84:1994;1442-1444.
17. Liu Q.Z., Knowler W.C., Nelson R.G.et al. Insulin treatment, endogenous insulin concentration and ECG abnormalities in diabetic Pima Indians: Cross-sectional and prospective analysis. Diabetes. 41:1992;1141-1150.
18. Saad M.F., Lillioja S., Nyomba B.L.et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 324:1991;733-739.
19. Welin L., Eriksson H., Ohlson L.O., Svardsudd K., Tibblin G. Hyperinsulinemia is not a major coronary artery risk factor in elderly men: The study of men born in 1913. Diabetologia. 35:1992;766-770.
20. Schmidt A.M., Hori O., Brett J., Yan S.D., Wautier J.L., Stern D. Cellular receptors for advanced glycation end products: Implications for induction of oxidant stress and cellular dysfunction in the pathogenesis of vascular lesions. Arterioscler Thromb. 14:1994;1521-1528.
21. Schmidt A.M., Hori O., Chen J.X.et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest. 96:1995;1395-1403.
22. Cruz A.B., Amatuzio D.S., Grande F., Hay L.J. Effect of intra-arterial insulin on tissue cholesterol and fatty acids in alloxan-diabetic dogs. Circ Res. 9:1961;39-43.
23. Sato Y., Shiraishi S., Oshida Y., Ishiguro T., Sakamoto N. Experimental atherosclerosis-like lesions induced by hyperinsulinism in Wistar rats. Diabetes. 38:1989;91-96.
24. Duff G.L., Brechin D.J.H., Finkelstein W.E. The effect of alloxan diabetes on experimental cholesterol atherosclerosis in the rabbit. IV. The effect of insulin therapy on the inhibition of atherosclerosis in the alloxan-diabetic rabbit. J Exper Med. 100:1954;371-380.
25. Nordestgaard B.G., Zilversmit D.B. Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J Lipid Res. 29:1988;1491-1500.
26. Hadcock S., Richardson M., Winocour P.D. Hatton MWC. Intimal alterations in the first six months of alloxan-induced diabetes. Arterioscler Thromb. 11:1991;517-529.
27. Richardson M., Hadcock S.J., DeReske M., Cybulsky M.I. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arterioscler Thromb. 14:1994;760-769.
28. Russell J.C., Graham S., Hameed M. Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism. 43:1994;538-543.
29. Russell J.C., Koeslag D.G., Amy R.M., Dolphin P.J. Plasma lipid secretion and clearance in hyperlipidemic JCR:LA-corpulent rats. Arteriosclerosis. 9:1989;869-876.
30. Vance J.E., Russell J.C. Hypersecretion of VLDL, but not H.D.L., by hepatocytes from the JCR:LA-corpulent rat. J Lipid Res. 31:1990;1491-1501.
31. McNamee C.J., Kappagoda C.T., Kunjara R., Russell J.C. Defective endothelium-dependent relaxation in the JCR:LA-corpulent rat. Circ Res. 74:1994;1126-1132.
32. Schneider D.J., Absher P.M., Neimane D., Russell J.C., Sobel B.E. Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood. Diabetologia, 41:1998;141-147.
33. Russell JC, Amy RM, Michaelis OE, McCune SM, Abraham AA. Myocardial disease in the corpulent strains of rats. In: Shafrir E, editor. Frontiers in Diabetes Research: Lessons from Animal Diabetes III. London: Smith-Gordon, 1990;402-407.
34. Russell J.C., Amy R.M. Myocardial and vascular lesions in the LA/N-cp rat. Can J Physiol Pharmacol. 64:1986;1272-1280.
35. Russell J.C., Amy R.M., Graham S.E., Dolphin P.J., Wood G.O., Bar-Tana J. Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by β,β′-tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb Vasc Biol. 15:1995;918-923.
36. Russell J.C., Dolphin P.J., Graham S.E., Amy R.M. Cardioprotective and hypolipidemic effects of nisoldipine in the JCR:LA-cp rat. J Cardiovasc Pharmacol. 29:1997;586-587.
37. DeLean A., Munson P.J., Rodbard D. Simultaneous analysis of families of sigmoid curves: Application to bioassay, radioligand assay, and physiological dose-response curves. Am J Physiol. 235:1978;E97-E102.
38. Pederson R.A., Campos R.V., Buchan A.M.J., Chisholm C.B., Russell J.C., Brown J.C. Comparison of the enteroinsular axis in two strains of obese rats: The fatty Zucker and JCR:LA-corpulent. Int J Obes. 15:1991;461-470.
39. Chan C.B., MacPhail R.M., Kibenge M.T., Russell J.C. Increased glucose phosphorylating activity correlates with insulin secretory capacity of male JCR:LA-corpulent rat islets. Can J Physiol Pharmacol. 73:1995;501-508.
40. Russell J.C., Graham S.E., Dolphin P.J., Brindley D.N. The effects of benfluorex on serum triacylglycerols and insulin sensitivity in the corpulent rat. Can J Physiol Pharmacol. 74:1996;879-886.
41. Russell J.C., Koeslag D.G., Dolphin P.J., Amy R.M. Beneficial effects of acarbose in the atherosclerosis-prone JCR:LA-corpulent rat. Metabolism. 42:1993;218-223.
42. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
43. Li H., Cybulsky M.I., Gimbrone M.A. Jr., Libby P. An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb. 13:1993;197-204.
44. O'Brien K.D., Allen M.D., McDonald T.O.et al. Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 92:1993;945-951.
45. Wood K.M., Cadogan M.D., Ramshaw A.L., Parums D.V. The distribution of adhesion molecules in human atherosclerosis. Histopathology. 22:1993;437-444.
46. Absher P.M., Schneider D.J., Balder L.C., Russell J.C., Sobel B.E. Increased proliferation of explanted vascular smooth muscle cells: A marker presaging atherogenesis. Atherosclerosis. 131:1997;187-194.
47. Russell JC. The atherosclerosis-prone JCR:LA-corpulent rat. In: Woodford FP, Davignon J, Sniderman A, editors. Atherosclerosis X: Proceedings of the 10th International Symposium on Atherosclerosis. Amsterdam: Elsevier Science, 1995;121-125.
48. Russell J.C., Amy R.M. Plasma lipids and other factors in the LA/N-corpulent rat in the presence of chronic exercise and food restriction. Am J Physiol Pharmacol. 64:1986;750-756.
49. Richardson M., Fletch A., Delaney K., DeReske M., Wilcox L.H., Kinlough-Rathbone R.L. Increased expression of vascular cell adhesion molecule-1 by aortic endothelial cells of rabbits with Pasteurella multocida pneumonia. Lab Animal Sci. 47:1997;52-60.
50. Fore W.W. Noninsulin-dependent diabetes mellitus: The prevention of complications. Med Clin North Am. 79:1995;287-298.
51. Henry R.R. Glucose control and insulin resistance in non-insulin-dependent diabetes mellitus. Ann Intern Med. 124(1, Pt. 2):1996;97-103.
52. Reichard P., Nilsson B.-Y., Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 329:1993;304-309.
53. Eschwege E., Fontbonne A. Hyperinsulinemia and macroangiopathy: The epidemiological perspective. Transplantation Proc. 24:1992;767-768.